PET-guided dose escalation tomotherapy in malignant pleural mesothelioma

Strahlentherapie und Onkologie

Volumn 187, Issue 11, 2011, Pages 736-743

  Fodor, Andrei ^a   Fiorino, Claudio ^a   Dell'Oca, Italo ^a   Broggi, Sara ^a   Pasetti, Marcella ^a   Cattaneo, Giovanni Mauro ^a   Gianolli, Luigi ^a   Calandrino, Riccardo ^a   Di Muzio, Nadia Gisella ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Helical tomotherapy; IGRT; Malignant pleural mesothelioma; PET imaging

Indexed keywords

CISPLATIN; GEMCITABINE; IMATINIB;

ARTERY THROMBOSIS; ARTICLE; ASTHENIA; CANCER CHEMOTHERAPY; CANCER INFILTRATION; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; COUGHING; DECORTICATION; DERMATITIS; DYSPHAGIA; DYSPNEA; FEMALE; GASTRITIS; HUMAN; LUNG DISEASE; LUNG RESECTION; LYMPH NODE; MALE; MALIGNANT PLEURAL MESOTHELIOMA; ODYNOPHAGIA; OVERALL SURVIVAL; PILOT STUDY; PLEURA MESOTHELIOMA; PLEURECTOMY; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; RADIATION DERMATITIS; RADIATION DOSE; RADIATION PNEUMONIA; STOMACH PAIN; THORAX PAIN; TOMOTHERAPY; VOMITING;

ADULT; AGED; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FATTY ACIDS; FEASIBILITY STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; PALLIATIVE CARE; PILOT PROJECTS; PLEURAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, COMPUTER-ASSISTED; RADIOTHERAPY, IMAGE-GUIDED; SALVAGE THERAPY; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 84856227197     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-2234-6     Document Type: Article

References (41)

1. Ahamad A, Stevens CW, Smithe WR et al. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2003;55:768-75. (Pubitemid 36170016)
2. Allen AM, Czerminska M, Janne PA et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 2006;65:640-5. (Pubitemid 43795851)
3. Allen AM, Den R, Wong JS et al. Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomy. Int J Radiat Oncol Biol Phys 2007;68:1366-74. (Pubitemid 47176807)
4. Benard F, Sterman D, Smith RJ et al. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest 1998;114(3):713-22. (Pubitemid 28433730)
5. Benard F, Sterman D, Smith RJ et al. Prognostic value of FDG PET imaging in malignant pleural mesothelioma. J Nucl Med 1999;40:1241-5. (Pubitemid 29385629)
6. Boutin, Rey F, Viallat J-R. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma: a randomized trial of local radiotherapy. Chest 1995;108:754-98.
7. Cattaneo GM, Dell'Oca I, Broggi S et al. Treatment planning comparison between conformal radiotherapy and helical tomotherapy in case of locally advanced stage NSCLC. Radiother Oncol 2008;88:310-8.
8. Chapman E, Berenstein EG, Dieguez M et al. Radiotherapy for malignant pleural mesothelioma (Review). Cochrane Database of Systematic Reviews 2006. Art. No.: CD003880.
9. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6.
10. Della Volpe A, Ferreri A, Annaloro C et al. Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total-body irradiation. Int J Radiat Oncol Biol Phys 2002;52:483-8. (Pubitemid 34170853)
11. Di Muzio N, Fiorino C, Cozzarini C et al. Phase I-II study of hypofractionated simultaneous integrated boost with tomotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2009;74:392-8.
12. Fiorino C, Alongi F, Broggi S et al. Physics aspects of prostate tomotherapy: planning optimization and image-guidance issues. Acta Oncol 2008;47: 1309-16.
13. Fodor A, Di Muzio N, Cattaneo M et al. Hemithoracic helical tomotherapy for malignant pleural mesothelioma. Radiother Oncol 2008;88:S281.
14. Flores RM. The role of PET in the surgical management of malignant pleural mesothelioma. Lung Cancer 2005;49(Suppl1):S27-S32. (Pubitemid 40798841)
15. Francis RJ, Byrne MJ, van der Schaaf AA et al. Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans. J Nucl Med 2007;48(9):1449-58. (Pubitemid 47397395)
16. Gerbaudo VH, Sugarbaker DJ, Britz-Cunningham S et al. Assessment of malignant pleural mesothelioma with 18F-FDG dual-head gamma camera coincidence imaging: comparison with histopathology. J Nucl Med 2002;43(9):1144-9. (Pubitemid 34988759)
17. Giaccone G. Pleural mesothelioma: combined modality treatments. Ann Oncol 2002;13(suppl 4):217-25. (Pubitemid 35363777)
18. Gupta V, Mychalczak B, Krug L et al. Hemithoracic radiation therapy after pleurectomy/decortications for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2005;63:1045-52. (Pubitemid 41505282)
19. Hakkinen AM, Laasonen A, Linnainmaa K et al. Radiosensitivity of mesothelioma cell lines. Acta Oncol 1996;35:451-6. (Pubitemid 26233050)
20. Herm H, Kaiser D, Grohé C et al. Helical intensity modulated radiation therapy (tomotherapy) in the primary treatment of pleural cancers. Strahlenther Onkol 2009;185:77
21. Kristensen CA, Nottrup TJ, Berthelsen AK et al. Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignat pleural mesothelioma. Radiother Oncol 2009;92:96-9.
22. Lammering G, De Ruysscher D, van Baardwijk A et al. The use of FDG-PET to target tumors by radiotherapy. Strahlenther Onkol 2010;9:471.
23. Lisenmeier C, Thoennessen D, Negretti L et al. Total body irradiation (TBI) in patients: a single-center experience after 30 years of low-dose rate irradiation. Strahlenther Onkol 2010;11:614.
24. Lee YC, Light RW, Musk AW. Management of malignant pleural mesothelioma: a critical review. Curr Opin Pulm Med 2000;6:267-74. (Pubitemid 30469223)
25. McAleer M, Tsao AS, Liao Z. Radiotherapy in malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2009;75:326-37.
26. Munter MW, Nill S, Thilmann C et al. Stereotactic intensity modulated radiation therapy (IMRT) and inverse treatment planning for advanced pleural mesothelioma. Feasibility and initial results, Strahelenther Onkol 2003;179:535-41. (Pubitemid 36966410)
27. Nakas A, Trousse DS, Martin-Ucar AE et al. Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy. Eur J Card Thorac Surg 2008;34:886-91.
28. Pagan V, Ceron L, Paccagnella A et al. 5-year prospective results of trimodality treatment for malignant pleural mesothelioma. J Cardiovasc Surg 2006;47:595-601. (Pubitemid 44696791)
29. Parker C, Neville E. Lung cancer. 8: Management of malignant mesothelioma. Thorax 2003;58:809-813. (Pubitemid 37094061)
30. Rice TW, Adelstein DJ, Kirby TJ et al. Aggressive multimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 1994;58:24-9. (Pubitemid 24243900)
31. Rice DR, Smythe WR, Liao Z et al. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2007;69:350-7. (Pubitemid 47381562)
32. Rusch VW. Pleurectomy/decortication in the setting of multimodality treatment for diffuse malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 1997;9:367-372.
33. Schneider DB, Clary-Macy C, Challa S et al. Positron emission tomography with F18- fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2000;120:128-33. (Pubitemid 30471221)
34. Sterzing F, chubert K, Sroka-Perez G, Kalz J, Debus J, Herfarth K. Helical tomotherapy. Experiences of the first 150 patients in Heidelberg. Strahelenther Onkol 2008, 184:8-14.
35. Sterzing F, Sroka-Perez G, Schubert K et al. Evaluating target coverage and normal tissue sparing in the adjuvant radiotherapy of malignant pleural mesothelioma: helical tomotherapy compared with step-and-shoot IMRT. Radiother Oncol 2008;86:251-7.
36. Sugarbaker DJ, Flores RM, Jaklitsch MT et al. Resection margins, extrapleural nodal status, and cell type to determine postoperative long-term survival in trimodal therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999;117:54-65. (Pubitemid 29022249)
37. Truong MT, Marom EM, Erasmus JJ. Preoperative evaluation of patients with malignant pleural mesothelioma: role of integrated CT-PET imaging. J Thorac Imaging 2006;21(2):146-53. (Pubitemid 43904262)
38. Ung YC, Yu E, Falkson C et al. The role of radiation therapy in malignant pleural mesothelioma: a systematic review. Radiother Oncol 2006;80:13-8. (Pubitemid 44205305)
39. Vogelzang NJ, Rusthoven J, Symanowski J et al. A phase III study of permetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636-44. (Pubitemid 46606305)
40. Wurstbauer K, Weise H, Deutschmann H et al. Non-small cell lung cancer in stages I-III B, long-term results of definitive radiotherapy with doses ≥ 80 Gy in standard fractionation. Strahlenther Onkol 2010;10:551.
41. Yajnik S, Rosenzweig KE, Mychalczak B et al. Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2003;56:1319-26. (Pubitemid 36842883)